Open AccessRadiation recall pneumonitis induced by epidermal growth factor receptor-tyrosine kinase inhibitor in patients with advanced nonsmall-cell lung cancer
Author(s) -
ChiLu Chiang,
Yiwei Chen,
Mei-Han Wu,
HuiChun Huang,
ChunMing Tsai,
ChaoHua Chiu
Publication year - 2016
Publication title -
journal of the chinese medical association
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.535
H-Index - 42
eISSN - 1728-7731
pISSN - 1726-4901
DOI - 10.1016/j.jcma.2016.01.008
Subject(s) - medicine , radiation pneumonitis , tyrosine kinase , tyrosine kinase inhibitor , epidermal growth factor receptor , pneumonitis , lung cancer , cancer research , lung , oncology , epidermal growth factor , cancer , receptor
Radiation recall pneumonitis (RRP) is a special form of radiation pneumonitis precipitated by certain pharmacological agents. Epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) is an effective treatment for advanced nonsmall-cell lung cancer (NSCLC) and has been reported as a potent radiation sensitizer. The incidence and general characteristics of EGFR-TKI-related RRP in patients with NSCLC remain unclear.